FXH 📈 First Trust Health Care - Overview
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US33734X1431 • Health
FXH: Healthcare, Pharmaceuticals, Biotechnology, Medical, Devices
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index. The index is a modified equal-dollar weighted index to objectively identify and select stocks from the Russell 1000® Index in the health care sector that may generate positive alpha relative to traditional passive-style indices through the use of the AlphaDEX® selection methodology. ‣ Company URL: http://www.ftportfolios.com/ ‣ Domicile: United States
Additional Sources for FXH ETF
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
FXH ETF Overview
| Market Cap in USD | 1,181m |
| Category | Health |
| TER | 0.62% |
| IPO / Inception | 2007-05-08 |
FXH ETF Ratings
| Growth 5y | 27.4% |
| Fundamental | - |
| Dividend | 25.7% |
| Rel. Strength Industry | -81.3 |
| Analysts | - |
| Fair Price Momentum | 96.55 USD |
| Fair Price DCF | - |
FXH Dividends
| Dividend Yield 12m | 0.32% |
| Yield on Cost 5y | 0.40% |
| Annual Growth 5y | 5.05% |
| Payout Consistency | 33.6% |
FXH Growth Ratios
| Growth Correlation 3m | -31.6% |
| Growth Correlation 12m | 66.3% |
| Growth Correlation 5y | 22.2% |
| CAGR 5y | 4.53% |
| CAGR/Mean DD 5y | 0.39 |
| Sharpe Ratio 12m | -0.10 |
| Alpha | -20.74 |
| Beta | 0.87 |
| Volatility | 16.81% |
| Current Volume | 27.8k |
| Average Volume 20d | 26.1k |
What is the price of FXH stocks?
As of December 22, 2024, the stock is trading at USD 105.22 with a total of 27,800 shares traded.
Over the past week, the price has changed by -1.89%, over one month by -2.56%, over three months by -6.42% and over the past year by +5.13%.
As of December 22, 2024, the stock is trading at USD 105.22 with a total of 27,800 shares traded.
Over the past week, the price has changed by -1.89%, over one month by -2.56%, over three months by -6.42% and over the past year by +5.13%.
Is First Trust Health Care a good stock to buy?
Neither. Based on ValueRay Analyses, First Trust Health Care is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 27.36 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of FXH as of December 2024 is 96.55. This means that FXH is currently overvalued and has a potential downside of -8.24%.
Neither. Based on ValueRay Analyses, First Trust Health Care is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 27.36 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of FXH as of December 2024 is 96.55. This means that FXH is currently overvalued and has a potential downside of -8.24%.
Is FXH a buy, sell or hold?
First Trust Health Care has no consensus analysts rating.
First Trust Health Care has no consensus analysts rating.
What are the forecast for FXH stock price target?
According to ValueRays Forecast Model, FXH First Trust Health Care will be worth about 106.9 in December 2025. The stock is currently trading at 105.22. This means that the stock has a potential upside of +1.63%.
According to ValueRays Forecast Model, FXH First Trust Health Care will be worth about 106.9 in December 2025. The stock is currently trading at 105.22. This means that the stock has a potential upside of +1.63%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 106.9 | 1.6% |